Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 2 ... Total Revenue Increased 18 Percent to $692 Million; GAAP Total Revenue $695 Million REVLIMID Net Product Sales Increased 31 Percent to $450 Million VIDAZA Net Product Sales ...
2009 SEP 7 ... and "unjust enrichment" regarding the Company's sale of thalidomide (THALOMID and REVLIMID ) for the treatment of multiple myeloma. The suit alleges that Ms. Jacobson developed ...
2009 NOV 23 ... from more than 200 recent and on-going clinical trials of Celgene products including REVLIMID®, VIDAZA®, THALOMID®, pomalidomide, ACE-011 and Amrubicin at the 51st ...
2009 NOV 1 ... 2010. A Phase 3 trial evaluating the combination of carfilzomib in combination with Revlimid and dexamethasone as a potential treatment option for patients with relapsed and ...
2009 NOV 1 ... patient population, as well as being well tolerated alone, or in combination with Revlimid. Upcoming data for carfilzomib could support the potential near-term introduction of a ...
2009 NOV 2 ... Research, Hematology, Lenalidomide, Lymphoma, Multiple Myeloma, Myeloma, Oncology, Revlimid, Therapy, Treatment. This article was prepared by Biotech Business Week ...
2009 OCT 12 ... Gene Therapy, Hematology, Lenalidomide, Myelodysplastic Syndromes, Phosphatase, Revlimid, Treatment. This article was prepared by Biotech Business Week editors from ...
2009 NOV 9 ... Lenalidomide, Lymphoma, Medical Device, Myelodysplastic Syndromes, Myeloma, Oncology, Revlimid, Therapy, Transfusion Medicine, Treatment. This article was prepared by ...
2009 OCT 12 ... Multiple Myeloma, Myeloma, Nephrology, Oncology, Pharmaceuticals, Renal Function, Revlimid, Thalidomide, Therapy, Treatment, University of Athens. This article was ...
2009 OCT 26 ... Chronic Lymphocytic Leukemia, Hematology, Lenalidomide, Mantle Cell Lymphoma, Oncology, Revlimid, National Heart, Lung, & Blood Institute. This article was prepared by ...
2009 NOV 9 ... Oncology, Drugs, Lenalidomide, Myelofibrosis, Oncology, Pharmaceuticals, Prednisone, Revlimid, Therapy, Treatment, University of Texas. This article was prepared by ...
2009 NOV 2 ... and refractory diffuse large B-cell lymphoma and dacetuzumab in combination with Revlimid® (lenalidomide) for relapsed and refractory multiple myeloma; in addition, ...
